Published by Benjamin Chiou on 22nd December 2023
(Sharecast News) - Biopharmaceuticals giant Bristol Myers Squibb has announced it is spending $14bn to purchase Karuna Therapeutics, which develops treatments for people living with psychiatric and neurological conditions.
URL: http://www.digitallook.com/dl/news/story/33990257/...